These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 24915493
21. The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1/Th2 balance and to modify the pancreatic microenvironment. Ezquer F, Ezquer M, Contador D, Ricca M, Simon V, Conget P. Stem Cells; 2012 Aug; 30(8):1664-74. PubMed ID: 22644660 [Abstract] [Full Text] [Related]
24. Hepatocyte growth factor is constitutively produced by donor-derived bone marrow cells and promotes regeneration of pancreatic beta-cells. Izumida Y, Aoki T, Yasuda D, Koizumi T, Suganuma C, Saito K, Murai N, Shimizu Y, Hayashi K, Odaira M, Kusano T, Kushima M, Kudano M. Biochem Biophys Res Commun; 2005 Jul 22; 333(1):273-82. PubMed ID: 15950193 [Abstract] [Full Text] [Related]
25. Evaluation of stem cell differentiation in diabetic rats transplanted with bone marrow mesenchymal stem cells. Lin P, Chen L, Yang N, Sun Y, Xu YX. Transplant Proc; 2009 Jun 22; 41(5):1891-3. PubMed ID: 19545751 [Abstract] [Full Text] [Related]
26. Hypoxic Preconditioning Improves the Therapeutic Potential of Aging Bone Marrow Mesenchymal Stem Cells in Streptozotocin-Induced Type-1 Diabetic Mice. Waseem M, Khan I, Iqbal H, Eijaz S, Usman S, Ahmed N, Alam G, Salim A. Cell Reprogram; 2016 Oct 22; 18(5):344-355. PubMed ID: 27500307 [Abstract] [Full Text] [Related]
27. Role of Hematopoietic Stem Cells in Inflammation of the Pancreas during Diabetes Mellitus. Dygai AM, Skurikhin EG, Pershina OV, Ermakova NN, Krupin VA, Ermolaeva LA, Stakheeva MN, Choinzonov EL, Goldberg VE, Reikhart DV, Ellinidi VN, Kravtsov VY. Bull Exp Biol Med; 2016 Feb 22; 160(4):474-9. PubMed ID: 26906195 [Abstract] [Full Text] [Related]
28. Insulin expressed from endogenously active glucose-responsive EGR1 promoter in bone marrow mesenchymal stromal cells as diabetes therapy. Chen NK, Tan SY, Udolph G, Kon OL. Gene Ther; 2010 May 22; 17(5):592-605. PubMed ID: 20182520 [Abstract] [Full Text] [Related]
29. Human umbilical cord-derived mesenchymal stem cells elicit macrophages into an anti-inflammatory phenotype to alleviate insulin resistance in type 2 diabetic rats. Xie Z, Hao H, Tong C, Cheng Y, Liu J, Pang Y, Si Y, Guo Y, Zang L, Mu Y, Han W. Stem Cells; 2016 Mar 22; 34(3):627-39. PubMed ID: 26523620 [Abstract] [Full Text] [Related]
30. Transplantation of insulin-producing cells derived from umbilical cord stromal mesenchymal stem cells to treat NOD mice. Wang HS, Shyu JF, Shen WS, Hsu HC, Chi TC, Chen CP, Huang SW, Shyr YM, Tang KT, Chen TH. Cell Transplant; 2011 Mar 22; 20(3):455-66. PubMed ID: 20719086 [Abstract] [Full Text] [Related]
31. Mesenchymal stem cells adopt beta-cell fate upon diabetic pancreatic microenvironment. Chang C, Wang X, Niu D, Zhang Z, Zhao H, Gong F. Pancreas; 2009 Apr 22; 38(3):275-81. PubMed ID: 19066494 [Abstract] [Full Text] [Related]
32. Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells into Insulin-Producing Cells: Evidence for Further Maturation In Vivo. Gabr MM, Zakaria MM, Refaie AF, Khater SM, Ashamallah SA, Ismail AM, El-Halawani SM, Ghoneim MA. Biomed Res Int; 2015 Apr 22; 2015():575837. PubMed ID: 26064925 [Abstract] [Full Text] [Related]
33. Can Stem Cells Ameliorate the Pancreatic Damage Induced by Streptozotocin in Rats? El Barky AR, Ezz AAH, Alm-Eldeen AA, Hussein SA, Hafez YA, Mohamed TM. Can J Diabetes; 2018 Feb 22; 42(1):61-70. PubMed ID: 28642056 [Abstract] [Full Text] [Related]
34. Bone marrow mesenchymal stromal cells rescue cardiac function in streptozotocin-induced diabetic rats. Monnerat-Cahli G, Trentin-Sonoda M, Guerra B, Manso G, Ferreira AC, Silva DL, Coutinho DC, Carneiro-Ramos MS, Rodrigues DC, Cabral-da-Silva MC, Goldenberg RC, Nascimento JH, Campos de Carvalho AC, Medei E. Int J Cardiol; 2014 Feb 01; 171(2):199-208. PubMed ID: 24374203 [Abstract] [Full Text] [Related]
35. Mesenchymal stem cell therapy ameliorates diabetic hepatocyte damage in mice by inhibiting infiltration of bone marrow-derived cells. Nagaishi K, Ataka K, Echizen E, Arimura Y, Fujimiya M. Hepatology; 2014 May 01; 59(5):1816-29. PubMed ID: 24375439 [Abstract] [Full Text] [Related]
36. Bone marrow-derived stem cells initiate pancreatic regeneration. Hess D, Li L, Martin M, Sakano S, Hill D, Strutt B, Thyssen S, Gray DA, Bhatia M. Nat Biotechnol; 2003 Jul 01; 21(7):763-70. PubMed ID: 12819790 [Abstract] [Full Text] [Related]
38. Increased β-cell replication and β-cell mass regeneration in syngeneically transplanted rat islets overexpressing insulin-like growth factor II. Estil les E, Téllez N, Escoriza J, Montanya E. Cell Transplant; 2012 Jul 01; 21(10):2119-29. PubMed ID: 22507193 [Abstract] [Full Text] [Related]
39. Hyperglycemia promotes vasculogenesis in choroidal neovascularization in diabetic mice by stimulating VEGF and SDF-1 expression in retinal pigment epithelial cells. Cai Y, Li X, Wang YS, Shi YY, Ye Z, Yang GD, Dou GR, Hou HY, Yang N, Cao XR, Lu ZF. Exp Eye Res; 2014 Jun 01; 123():87-96. PubMed ID: 24780853 [Abstract] [Full Text] [Related]
40. Making surrogate β-cells from mesenchymal stromal cells: perspectives and future endeavors. Bhonde RR, Sheshadri P, Sharma S, Kumar A. Int J Biochem Cell Biol; 2014 Jan 01; 46():90-102. PubMed ID: 24275096 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]